ArticleJournal of experimental & clinical cancer research : CR2022

Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcoma.

Mingrui Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.